1. "2017"
  2. "Ferrata Storti Foundation"
Formats
  1. Meeting Abstract (37)
  2. Journal Article (5)
Groups
  1. Center for Hematologic Malignancies (36)
  2. Department of Medicine (36)
  3. Hematologic Malignancies, Division of (36)
  4. Adult Leukemia (12)
  5. Bone Marrow Transplant (12)
  6. GSK Faculty (7)

More Groups

People
  1. Nancy Kernan (6)
  2. Sergio Giralt (6)
  3. Carl Landgren (5)
  4. Michael Mauro (5)
  5. Eytan Stein (4)
  6. Heather Landau (4)

More People

Years
  1. 2017 (42)
Publications
  1. Haematologica (42)
Publishers
  1. Ferrata Storti Foundation (42)

Results (42)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The dual SYK/JAK inhibitor cerdulatinib demonstrates complete inhibition of SYK and JAK and rapid tumor responses in a phase 2 study in patients with relapsed/refractory B cell malignancies
    Meeting Abstract

    Hamlin, P.; Farber, C.; Fenske, T.; Khatcheressian, J.; Miller, C.; Munoz, J.; Patel, M.; Smith, S.; Stevens, D.; Pandey, A.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Analysis of the genomic landscape of multiple myeloma highlights novel candidate prognostic markers and disease subgroups
    Meeting Abstract

    Bolli, N.; Biancon, G.; Moarii, M.; Gimondi, S.; Li, Y.; De Philippis, C.; Maura, F.; Sathiaseelan, V.; Yu-Tzu, T.; Mudie, L.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Pooled survival analysis of midostaurin clinical study data (D2201+A2213) in patients with advanced systemic mastocytosis compared with historical controls
    Meeting Abstract

    Reiter, A.; Kluin-Nelemans, H. C.; George, T.; Akin, C.; DeAngelo, D. J.; Hermine, O.; Awan, F.; Hexner, E.; Mauro, M.; Schwaab, J.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • 21-color flow cytometry reveals immunophenotypes associated with response in acute graft-versus-host disease patients treated with the Janus kinase inhibitor INCB039110
    Meeting Abstract

    Staser, K.; Choi, J.; Khoury, J.; Jagasia, M.; Ali, H.; Schiller, G.; Arbushites, M.; Delaite, P.; Yan, Y.; Rhein, K.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Efficacy and safety of defibrotide to treat hepatic veno-occlusive disease/sinusoidal obstruction syndrome post-chemotherapy: A post hoc analysis of final data of an expanded-access protocol
    Meeting Abstract

    Kernan, N.; Richardson, P.; Grupp, S.; Antin, J.; Messinger, Y.; Liang, W.; Ryan, R.; Hume, R.; Tappe, W.; Soiffer, R.
    Haematologica (2017)

    Fulltext@MSK | Save
  • Analysis of dasatinib and imatinib 5-year efficacy and safety based on baseline comorbidity and age in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) in DASISION
    Meeting Abstract

    Saglio, G.; Cortes, J. E.; Hochhaus, A.; Shah, N. P.; Atallah, E. L.; Abaskharoun, M.; Li, L.; Mauro, M. J.
    Haematologica (2017)

    Fulltext@MSK | Save
  • Case-based learning in continuing education: Improving hematologist/oncologist evidence-based decisions for preventing Hogdkin lymphoma post-transplant relapse
    Meeting Abstract

    Repetto, P.; Moskowitz, C.
    Haematologica (2017)

    Fulltext@MSK | Save
  • Multiple myeloma and comorbidity: A population-based study
    Meeting Abstract

    Sverrisdottir, I. S.; Rögnvaldsson, S.; Lund, S. H.; Turesson, I.; Hultcrantz, M.; Björkholm, M.; Landgren, O.; Kristinsson, S. Y.
    Haematologica (2017)

    Fulltext@MSK | Save
  • Prognostic tools can provide personalized outcomes prediction after allogeneic HCT in patients with hematologic malignancies
    Meeting Abstract

    Cho, C.; Devlin, S.; Hilden, P.; Maloy, M.; Horowitz, M.; Rizzo, J. D.; Logan, B.; Barba, P.; O'Reilly, R.; Giralt, S.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Durable long-term survival of adult patients with B-ALL after CD19 CAR (19-28z) T cell therapy
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Senechal, B.; Wang, Y.; Purdon, T.; Brentjens, R.; Sadelain, M.
    Haematologica (2017)

    Fulltext@MSK | Save